Psyomics, a UK-based mental health diagnosis spinout from University of Cambridge, has raised an undisclosed sum of funding from University of Cambridge Enterprise Fund V and Parkwalk Opportunities Fund.
University of Cambridge Enterprise Fund invests in Cambridge technologies behalf of university alumni and the private sector, while Parkwalk Opportunities Fund backs UK-based technology businesses under a government tax break scheme.
Both vehicles are operated by commercialisation firm Parkwalk Advisors.
PsyOmics is developing a mental health diagnosis tool that uses biomarker…
